NOV 08, 2018 5:00 PM CST

NMR in standardizing biomarkers for personalized medicine: Where do biobanks come in? (For research use only)

Sponsored by: Bruker
Speaker
  • Universitätsmedizin Greifswald, Institut für Klinische Chemie und Laboratoriumsmedizin, Ferdinand-Sauerbruch-Straße, 17475 Greifswald
    BIOGRAPHY

Abstract
DATE: November 9, 2018
TIME: 9:00am CST, 10:00am JST, 12:00pm AEDT
 
Personalized and precision medicine are rapidly growing areas that require high quality spectral as well as metadata to categorize patients. Standardized spectral data are key to identify biomarkers or patterns of multiple biomarkers. Correct description of the natural variation in body fluids of healthy cohorts is the basis to correct outlier signal identification describing deviations from normality. Giving access to a large number of samples and spectroscopy data thereof is a task, that can be fulfilled by biobanks.  Based on the reproducibility and transferability of nuclear magnetic resonance (NMR) multiple biobanks under standardization can deliver NMR spectra instead of Aliquots, to be used in clinical trials or clinical and translational research. Such NMR spectra can in first place be used for extensive quality control of biobank specimens and creating large amounts of quantification results e.g. in plasma/serum and urine. Such results can be stored with the metadata for each sample.
 
The Bruker IVDr Platform and embedded solutions for biobanking will be shortly introduced before Prof Nauck takes over and presents results obtained analyzing plasma/serum and urine NMR-spectral data generated under fully standardized condition in targeted and untargeted mode. It will also be shown how lipoprotein subclass analysis and small molecule quantification in plasma/serum as well as quantification of urinary metabolites can support the development of diagnostic routines.
 
In addition, Prof. Nauck will highlight the need for high quality biobanking and the benefit of applying NMR analysis on biobank specimen. Providing access to fully standardized spectra produced as part of the biobank QC forms a major contribution to clinical and translational research.
 
Viewers can expect to see the following key topics:
  • Saving time and cost by providing NMR spectra under standardized conditions from each biobank sample as part of the QC and storing them into the biobank together with quantification results. Biobank clusters using the standardized NMR approach will rapidly grow, providing exchangeable spectra.
  • Development of potential new diagnostic methods under standardized NMR conditions, be it in precision medicine or using epidemiological approaches.
 
Who should attend:
 
The webinar will be of interest to biobanks, hospitals that have biorepositories, pharmaceutical companies in development and clinical trials, epidemiologist and laboratories that are interested in optimizing NMR spectroscopic techniques methods, which can contribute to a system biology approach.
 
Important note: The methods and solutions discussed during the webinar are for research use only and not for use in clinical diagnostic procedures.

Show Resources
You May Also Like
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
OCT 20, 2021 10:00 AM PDT
C.E. CREDITS
OCT 20, 2021 10:00 AM PDT
Date: October 20, 2021 Time:10:00am (PDT), 1:00pm (EDT) As the prevalence of Diabetes continues to rise in many areas across the globe, healthcare providers continue to look for methods that...
JUN 03, 2021 12:00 PM CST
JUN 03, 2021 12:00 PM CST
DATE: June 3, 2021 TIME: 12:00pm SGT This webinar is a virtual event that focuses on utilizing the Gibco CTS Rotea System for Cell and Gene Therapy...
APR 21, 2021 10:00 AM PDT
C.E. CREDITS
APR 21, 2021 10:00 AM PDT
Date: April 21, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Serological testing for SARS-CoV-2 has been steadily adopted into clinical practice over the course of this pandemic. In this webinar,...
NOV 08, 2018 5:00 PM CST

NMR in standardizing biomarkers for personalized medicine: Where do biobanks come in? (For research use only)

Sponsored by: Bruker

Specialty

Cancer Research

Molecular Biology

Cell Biology

Genetics

Biotechnology

Clinical Research

Medicine

Biomarkers

Clinical Diagnostics

Cancer Diagnostics

Laboratory Testing

Diagnostics

Cancer Therapeutics

Biochemistry

Bioinformatics

Geography

North America40%

Europe26%

Asia19%

Africa8%

South America6%

Registration Source

Website Visitors83%

Email Promotions7%

Client/Sponsor Promotions2%

WAVE Newsletter Promotion2%

Social Media Promotions1%

Trending Newsletter Promotion1%

Other2%

Job Title

Student26%

Research Scientist13%

Educator/Faculty12%

Medical Laboratory Technician9%

Medical Doctor/Specialist7%

Executive7%

Post Doc6%

Clinical Laboratory Scientist4%

Scientist4%

Facility/Department Manager4%

Lab Management2%

Pathologist1%

Consultant1%

Chemist1%

Veterinarian1%

Biologist1%

Organization

Academic Institution22%

Research Institute16%

Hospital11%

Medical School10%

Clinical Laboratory5%

Medical Center5%

Government4%

Pharmaceutical Company4%

Life Science Company3%

Biotech Company3%

Non-Profit Organization2%

Industrial Company2%

Consultant1%

Animal Hospital1%

Other6%


Show Resources
Loading Comments...
Show Resources